TET2 c.773A>G ;(p.N258S)

Variant ID: 4-106155872-A-G

NM_001127208.2(TET2):c.773A>G;(p.N258S)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Personalized First-Line Treatment of Metastatic Pancreatic Neuroendocrine Carcinoma Facilitated by Liquid Biopsy and Computational Decision Support.

Diagnostics (Basel, Switzerland)
Szkukalek, Judita J; Dóczi, Róbert R; Dirner, Anna A; Boldizsár, Ákos Á; Varga, Ágnes Á; Déri, Júlia J; Lakatos, Dóra D; Tihanyi, Dóra D; Vodicska, Barbara B; Schwáb, Richárd R; Pajkos, Gábor G; Várkondi, Edit E; Vályi-Nagy, István I; Valtinyi, Dorottya D; Nagy, Zsuzsanna Z; Peták, István I
Publication Date: 2021-10-07

Variant appearance in text: TET2: 773A>G
PubMed Link: 34679548
Variant Present in the following documents:
  • diagnostics-11-01850.pdf
View BVdb publication page



appreci8: a pipeline for precise variant calling integrating 8 tools.

Bioinformatics (Oxford, England)
Sandmann, Sarah S; Karimi, Mohsen M; de Graaf, Aniek O AO; Rohde, Christian C; Göllner, Stefanie S; Varghese, Julian J; Ernsting, Jan J; Walldin, Gunilla G; van der Reijden, Bert A BA; Müller-Tidow, Carsten C; Malcovati, Luca L; Hellström-Lindberg, Eva E; Jansen, Joop H JH; Dugas, Martin M
Publication Date: 2018-12-15

Variant appearance in text: TET2: 773A>G; Asn258Ser
PubMed Link: 29945233
Variant Present in the following documents:
  • bty518_supplementary_data_s2.xlsx, sheet 8
View BVdb publication page